{"id":"https://openalex.org/W2912728353","doi":null,"title":"Efficacy and Mechanism of Action of the Novel Bromodomain Inhibitor, PLX51107, in B Cell Malignancies","display_name":"Efficacy and Mechanism of Action of the Novel Bromodomain Inhibitor, PLX51107, in B Cell Malignancies","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2912728353","mag":"2912728353"},"language":"en","primary_location":{"id":"mag:2912728353","doi":null,"is_oa":false,"landing_page_url":"https://www.imedpub.com/articles/efficacy-and-mechanism-of-action-of-the-novel-bromodomain-inhibitor-plx51107-in-b-cell-malignancies.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2754208000","display_name":"Journal of medical research/The journal of medical research","issn_l":"0097-3599","issn":["0097-3599"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of medical research/\u0098The \u009cjournal of medical research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078705613","display_name":"Monica Diane Mead","orcid":"https://orcid.org/0000-0001-9175-0189","observed_orcids":["https://orcid.org/0000-0001-9175-0189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Mead","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9175-0189","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045874340","display_name":"Erika von Euw","orcid":"https://orcid.org/0000-0002-3201-3311","observed_orcids":["https://orcid.org/0000-0002-3201-3311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika von Euw","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3201-3311","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045387212","display_name":"Dylan F. Conklin","orcid":"https://orcid.org/0000-0003-4708-0071","observed_orcids":["https://orcid.org/0000-0003-4708-0071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dylan Conklin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4708-0071","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064453119","display_name":"Kanthinh Manivong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kanthinh Manivong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075434320","display_name":"Eileen Do","orcid":"https://orcid.org/0000-0001-9631-9101","observed_orcids":["https://orcid.org/0000-0001-9631-9101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eileen Do","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9631-9101","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Larson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4335-2925","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.13820642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brd4-inhibitors","display_name":"BRD4 inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/bromodomain-inhibitors","display_name":"bromodomain inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/c-myc-downregulation","display_name":"c-Myc downregulation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8100000023841858},{"id":"https://openalex.org/keywords/premature-senescence","display_name":"premature senescence","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.925000011920929},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8330000042915344}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6575791835784912},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.6423215866088867},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5878361463546753},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.5758642554283142},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5549675226211548},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.5456422567367554},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5390626192092896},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5372521877288818},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5352352857589722},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5176949501037598},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5011296272277832},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.47245171666145325},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.4671069383621216},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4479047954082489},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.43156522512435913},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.43099167943000793},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4145798683166504},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3097189664840698},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18947583436965942},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14206814765930176},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14171940088272095},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08045503497123718}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2912728353","doi":null,"is_oa":false,"landing_page_url":"https://www.imedpub.com/articles/efficacy-and-mechanism-of-action-of-the-novel-bromodomain-inhibitor-plx51107-in-b-cell-malignancies.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2754208000","display_name":"Journal of medical research/The journal of medical research","issn_l":"0097-3599","issn":["0097-3599"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of medical research/\u0098The \u009cjournal of medical research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9535999894142151,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2549238568","https://openalex.org/W4310127439","https://openalex.org/W4230336539","https://openalex.org/W2786719846","https://openalex.org/W3095947069","https://openalex.org/W2028322760","https://openalex.org/W2998488866","https://openalex.org/W2567290660","https://openalex.org/W2748639442","https://openalex.org/W2052787205"],"abstract_inverted_index":{"BRD4":[0,20,31],"functions":[1],"as":[2],"an":[3],"important":[4],"epigenetic":[5],"regulator":[6],"of":[7,9,17,28,30,45,50,69,80,84,91,103,133,138],"transcription":[8],"pathways":[10,60,109],"involved":[11,116],"in":[12,42,88,105,110,117,122],"oncogenesis.":[13],"While":[14],"down":[15,89,136],"regulation":[16,90,137],"c-myc":[18,140],"following":[19],"inhibition":[21],"has":[22,131],"been":[23],"described,":[24],"the":[25,41,58,101,139],"exact":[26],"mechanism":[27],"action":[29,134],"inhibitors":[32],"across":[33,47],"B":[34,51],"cell":[35,52,55,75,112,124],"malignancies":[36],"remains":[37],"unclear.":[38],"We":[39],"demonstrate":[40,128],"vitro":[43],"efficacy":[44],"PLX51107":[46,62,99,130],"a":[48,145],"spectrum":[49],"lymphoma":[53],"(BCL)":[54],"lines":[56],"and":[57,78,94,143],"signaling":[59],"involved.":[61],"demonstrated":[63],"potent":[64],"anti-tumor":[65],"effects":[66],"(median":[67],"IC50":[68],"300":[70],"NM),":[71],"primarily":[72],"driven":[73],"by":[74],"cycle":[76],"arrest":[77],"induction":[79],"premature":[81],"senescence.":[82],"Treatment":[83],"BCL":[85],"cultures":[86],"resulted":[87],"c-myc,":[92],"p-IRAK,":[93],"P-MAPK":[95],"Erk":[96],"1/":[97],"2.":[98],"affected":[100,121],"expression":[102],"proteins":[104,115],"several":[106],"critical":[107],"cellular":[108],"sensitive":[111],"lines,":[113],"while":[114],"drug":[118],"resistance":[119],"were":[120],"resistant":[123],"lines.":[125],"These":[126],"results":[127],"that":[129],"mechanisms":[132],"beyond":[135],"transcriptional":[141],"program":[142],"is":[144],"promising":[146],"targeted":[147],"therapeutic":[148],"agent.":[149]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}